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Background: Analgesia after Cesarean delivery (CD) requires early ambulation to prevent thromboembolic disease
and to facilitate baby care. We retrospectively reviewed anesthesia charts and medical records of patients who
underwent CD to compare the efficacy of spinal anesthesia supplemented with intrathecal morphine hydrochloride
(ITM) and combined spinal–epidural anesthesia followed by opioid-free epidural analgesia (CSEA-EDA).
Findings: All subjects underwent CD at Nagaoka Chuo General Hospital between February 2012 and January 2013.
Patient characteristics, time to first analgesic rescue after CD, and analgesic use after CD were examined. Incidences
of postural hypotension, lower extremity numbness/weakness, postoperative nausea/vomiting (PONV), and pruritus
were also examined for 48 h after CD. Average time to first analgesic use after CD (ITM 25.13 ± 16.07 h, CSEA-EDA
22.42 ± 16.27 h, p = 0.521) and cumulative probability of rescue analgesic use (p = 0.139 by log-rank test) were
comparable between groups. However, average analgesic use within 24 h was lower in the ITM group (0.75 ± 1.05
times) than in the CSEA-EDA group (1.52 ± 1.72 times, p = 0.0497). Numbness or motor weakness in lower
extremities only occurred in the CSEA-EDA group, and pruritus only occurred in the ITM group.
Conclusions: The results of this study suggest that ITM is better than CSEA-EDA for anesthesia following CD with
regard to pain control. Also, ITM would be advantageous for early ambulation following CD because of lower
incidence of numbness and motor weakness in lower extremities compared to CSEA-EDA.
Keywords: Cesarean delivery; Spinal anesthesia with intrathecal morphine; Opioid-free epidural analgesia;
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Introduction
A Cesarean section is one of the most commonly per-
formed surgical procedures. Combined spinal–epidural
anesthesia (CSEA) is a favorable neuraxial anesthetic tech-
nique for Cesarean deliveries (CD) because the epidural
catheter can also be utilized for postoperative patient-
controlled epidural analgesia. However, postoperative epi-
dural analgesia frequently causes lower extremity numbness
and weakness, which can delay early ambulation [1, 2].* Correspondence: y-kamiya@med.niigata-u.ac.jp
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provided the original work is properly creditedOpioid-supplemented epidural analgesia after CD can pro-
vide superior analgesia and has a low incidence of lower ex-
tremity numbness and weakness [3, 4]. However, opioid
supplementation in continuous epidural analgesia can lead
to postoperative nausea and vomiting (PONV), which hin-
ders early ambulation and recovery. Moreover, in the
perinatal period, women are more susceptible to thrombo-
embolic disease, and perioperative anticoagulant therapy is
recommended to prevent thromboembolic disease during
pregnancy. Unfortunately, anticoagulants can make epi-
dural catheter handling more difficult.
Morphine-supplemented spinal anesthesia [5], or
single-shot intrathecal morphine (ITM), can rapidly in-
duce anesthesia and provide long-term postoperative
pain relief for elective and emergency CDs. Therefore,
ITM may allow for early ambulation after CD, which re-
duces the risk thromboembolic disease and facilitatesicle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
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ated with PONV, pruritus, sedation, and respiratory de-
pression [5, 6].
Numerous clinical studies have evaluated the efficacy
of ITM and CSEA followed by epidural analgesia in pa-
tients undergoing CD. To the best of our knowledge, no
study has directly compared anesthesia efficacy and ad-
verse effect incidences between ITM and CSEA with
opioid-free epidural analgesia (CSEA-EDA) within 48 h
of CD. We retrospectively examined and compared the




This retrospective cohort study was performed at Nagaoka
Chuo General Hospital. The study was reviewed and
approved by the Nagaoka Chuo General Hospital institu-
tional review board. Anesthesia charts and medical re-
cords of consecutive patients who underwent CD between
February 2012 and January 2013 were reviewed. Patients
that underwent spinal anesthesia without ITM or general
anesthesia for CD were excluded from analyses.
Analgesic methods
The ITM group received 0.5 % hyperbaric bupivacaine
(8.5–12 mg) supplemented with 100 μg of intrathecal
preservative-free morphine hydrochloride. The CSEA-
EDA group had an epidural catheter inserted at the T11/
12, T12/L1, or L1/2 intervertebral space using standard
procedures. After test dose administration (3 mL bolus
of 1 % mepivacaine), 0.5 % hyperbaric bupivacaine (3.5–
9.0 mg) was administered into the intrathecal space.
Epidural 0.75 % ropivacaine (5–12 mL) was given as
needed to obtain a block of adequate height. Immedi-
ately after surgery, 0.2 % ropivacaine was administered
through the epidural catheter (4 mL/h) using a dispos-
able infuser (Coopdeck Baloonjector 300 with PCA ap-
paratus, Daiken Medical, Osaka, Japan). The CSEA-EDA
group had anesthesia administered by one physician
(KS), and the ITM group had anesthesia administered by
two physicians (HS or TF).
All patients were mobilized 6–8 h after surgery. Based
on pain level and patient requests, rescue analgesics were
administered to manage postoperative breakthrough pain
(numeric rating scale [NRS] ≥ 3–4). Patients were first ad-
ministered suppository diclofenac sodium (50 mg) or oral
loxoprofen sodium (60 mg). The CSEA-EDA group had
the option of patient-controlled epidural anesthesia
(PCEA; 0.2 % ropivacaine 3 mL, lockout interval of
60 min) for initial rescue analgesic administration. If pain
persisted, intramuscular pentazocine (30 mg) was given.
Acetaminophen (400 mg) was used as an alternative or
supplementation to NSAID analgesia, if needed.Data were collected within 48 h of CD and included
patient characteristics, time to first rescue analgesic use,
rescue analgesic use frequency, and adverse event (pos-
tural hypotension, lower extremity numbness and weak-
ness, PONV, and pruritus) incidences. Primary outcomes
included time to first rescue analgesic use and rescue an-
algesic use frequency. Secondary outcomes were the in-
cidences of adverse effects within 48 h of CD.
Data analyses
Continuous variables are presented as mean ± standard
deviation. Categorical variables, ordinal variables, and
non-normally distributed data are presented as median
(range). All statistical analyses were performed using
Microsoft Excel 2011 for Macintosh (Microsoft, Redmond,
WA, USA) with a statistical macro (XLSTAT 2014;
Addinsoft, New York, NY, USA). An unpaired t test or
Mann–Whitney U-test was used to determine statistical
significance of differences in patient characteristics. A log-
rank test was used to compare cumulative probabilities. A
Kolmogorov–Smirnov test was used to compare time dis-
tribution of rescue analgesic use. Patients who did not
require rescue analgesics were assigned a first use time of
48 h. The comparisons of frequency of rescue analgesic
use within 48 h after CD and the average time to first
rescue analgesic use between groups in which the epidural
puncture was performed were made using Kruskal–Wallis
test and one-way analysis of variance (ANOVA), respect-
ively. The comparisons between groups in which epidural
analgesia was continued or discontinued within 48 h after
CD were performed using Mann–Whitney U-test and un-
paired t test, respectively. Incidences of anesthesia-related
adverse effects were compared using Fisher’s exact tests.
Statistical significance was defined as p < 0.05.
Results
Eighty-five patients underwent CDs which occurred during
the study period, of which 32 and 27 patients were included
in the ITM and CSEA-EDA groups, respectively. Patient
demographic characteristics are summarized in Table 1. No
significant differences between groups were observed in
age, height, body weight, gestational week, and emergency
CD rate. The number of cases per site of epidural puncture
in CSEA procedure was as follows: T11/12, n = 8; T12/L1,
n = 12; and L1/2, n = 7. Average time to first rescue anal-
gesic use (including patient-controlled local anesthetic
bolus infusion in the CSEA-EDA group) was not statisti-
cally different between groups (ITM 25.13 ± 16.07 h,
CSEA-EDA 22.42 ± 16.27 h, p = 0.521, unpaired t test).
Moreover, the cumulative probability of rescue analgesic
and/or PCEA use was not significantly different between
groups (Fig. 1). The percentage of patients using rescue an-
algesics within 48 h of CD was similar between groups
(ITM 25 of 32 patients [78.1 %], CSEA-EDA 22 of 27







Age (years) 33.6 ± 5.2 31.4 ± 4.1 0.24
Height (cm) 158 ± 5.3 157 ± 4.1 0.30
Weight (kg) 64.3 ± 9.3 63.4 ± 8.9 0.62
Gestational week 38.0 ± 1.7 38.5 ± 2.1 0.55
Emergency CD incidence 11 (34 %) 12 (44 %) 0.30
Data are shown as mean ± SD or as actual incidence number (percentage of
total patients). An unpaired t test was used to analyze the age, height, weight,
and gestational week; Fisher’s exact test was used to analyze the incidences of
emergency CD
ITM intrathecal morphine-supplemented spinal anesthesia, CSEA-EDA com-
bined spinal–epidural anesthesia followed by opioid-free epidural analgesia,
CD Cesarean delivery
Fig. 1 Cumulative probability of rescue analgesic use after Cesarean
delivery. There was no significant difference in the cumulative
probability of rescue analgesic use within 48 h of Cesarean delivery
in patients receiving single-shot spinal analgesia (ITM group) and
combined spinal–epidural anesthesia followed by opioid-free
epidural analgesia (CSEA-EDA group, p = 0.138 by log-rank test)
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was significantly lower in the ITM group (0 time [range 0–
3]) than in the CSEA-EDA group (1 time [0–6], p = 0.0497)
within 24 h of CD, but not in the 24–48 h after CD (ITM 2
times [0–4], CSEA-EDA 1 time [0–5], p = 0.465; Fig. 2).
The frequency of rescue analgesic use within 48 h of CD
and the average time to first rescue analgesic use were not
significantly different between the groups in which the epi-
dural puncture was performed (Table 2).
Analgesia-related adverse effects occurred within 48 h
in both groups. Lower extremity numbness and weaknessFig. 2 Relative frequency of rescue analgesic usage within 24 h of Cesarea
single-shot spinal analgesia (ITM group) and combined spinal–epidural ane
Within 24 h of CD, the relative frequency and distribution of rescue analge
in the CSEA-EDA group (1 time [0–6], p = 0.0497 by Mann–Whitney U-test,
24 and 48 h after CD was not significantly different between groups (ITM 2
U-test, p = 0.465 by Kolmogorov–Smirnov test). Vertical bar charts represent
represent the cumulative frequency of rescue analgesic use in each group.only occurred in the CSEA-EDA group, and pruritus only
occurred in the ITM group (Table 3). The incidence of
numbness or motor weakness in CSEA-EDA group was as
follows: T11/12, n = 2; T12/L1, n = 4; and L1/2, n = 3. The
odds ratio of incidence of numbness or motor weaknessn delivery (CD) and between 24 and 48 h after CD in patients receiving
sthesia followed by opioid-free epidural analgesia (CSEA-EDA group).
sic use in the ITM group (ITM 0 times [range 0–3]) was lower than that
p = 0.019 by Kolmogorov–Smirnov test). Rescue analgesic use between
times [0–4], CSEA-EDA 1 time [0–5], p = 0.416 by Mann–Whitney
the relative frequency of rescue analgesic use in each group. Line plots
Data are presented as median [range]
Table 2 Frequency of rescue analgesic use and average time to
first rescue analgesic use within 48 h after CD between the
groups, in which the epidural puncture was performed








analgesic use after CD
(times)
<24 h 1 [0–6] 0 [0–3] 1 [0–5] 0.59
24–
48 h
0 [0–3] 1 [0–4] 2 [0–5] 0.09
<48 h 1 [0–9] 2 [0–6] 4 [1–
11]
0.1









Data are shown as median [range] or mean+/-SD. Statistical analyses were
performed by Kruskal–Wallis test for frequency of rescue analgesic use and by one-
way ANOVA for average time to first rescue analgesic use within 48 h after CD
CD Cesarean delivery





group (n = 27)
p-
value
Postural hypotension 2 (6.3 %) 6 (22.2 %) 0.08
PDPH – 2 (7.4 %) 0.21
Numbness in the lower
extremities 24 h after CD
– 9 (33.3 %) <0.001
PONV 2 (6.3 %) 2 (7.4 %) 0.63
Pruritus 12 (37.5 %) – <0.001
Catheter trouble – 5 (18.5 %) –
Data are shown as actual incidence number (percentage of total patients).
Statistical analyses were performed by Fisher’s exact test
CD Cesarean delivery, ITM intrathecal morphine-supplemented spinal
anesthesia, CSEA-EDA combined spinal–epidural anesthesia followed by
opioid-free epidural analgesia, PDPH postdural puncture headache, PONV post-
operative nausea and vomiting
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which the epidural puncture was performed. Postural
hypotension occurred more often in the CSEA-EDA
group, but the difference was not statistically significant
(p = 0.08). Five of 27 patients (18.5 %) in the CSEA-EDA
group had epidural catheter issues (i.e., connector trouble
or local anesthetic leakage from catheter insertion site).
Catheter issues led to obstetrician removal of the catheter
within 48 h of CD in 12 of 27 patients (44.4 %) in the
CSEA-EDA group. The frequency of rescue analgesic use
within 24 h of CD and the average time to first rescue an-
algesic use were not significantly different between groups
that discontinued epidural analgesia within 48 h of CD
and those that continued analgesia (Table 4). Respiratory
depression was not observed in any patient in either
group.Discussion
This small retrospective study revealed that the ITM
group required fewer analgesic interventions than the
CSEA-EDA group within 24 h of CD. Additionally, fewer
adverse effects that impeded early ambulation (lower ex-
tremity numbness and weakness, orthostatic hypotension)
occurred in the ITM group than in the CSEA-EDA group.Table 4 Frequency of rescue analgesic use and average time to firs
in which the postoperative epidural analgesia was continued for 48
Contin
(15/27
Frequency of rescue analgesic use after CD (times) <24 h 1 [0–6
24–48 h 0.5 [0–
<48 h 1.5 [0–
Average time to first rescue analgesic use (hh:mm) 21:16 ±
Data are shown as median [range] or mean+/-SD. Statistical analyses were performe
unpaired t test in average time to first rescue analgesic use within 48 h after CD
CD Cesarean deliveryIntrathecal opioids are effective for managing postopera-
tive pain after CD but are associated with pruritus, PONV,
and respiratory depression [5–7]. Lower extremity numb-
ness more than 24 h after CD and respiratory depression
were not observed in the ITM group. Additionally, PONV
incidence in the ITM group was not statistically different
than in the CSEA-EDA group. Previous studies have
shown that respiratory depression is very rare in patients
undergoing CD with morphine-supplemented spinal
anesthesia [8]. Moreover, 0.1 mg of morphine sufficiently
reduces postoperative pain with little respiratory depres-
sion [5, 9].
Previous studies demonstrated that CSEA-EDA ad-
equately manages postoperative pain after CD and has a
low incidence of adverse effects (PONV and hypotension)
[10, 11]. However, early ambulation after CD is important
to prevent thromboembolic diseases and to facilitate in-
fant breastfeeding and care. Therefore, postoperative epi-
dural analgesia may be disadvantageous because epidural
analgesia with local anesthetics causes lower extremity
numbness and weakness. Previous reports found lower ex-
tremity weakness incidences of 26 % [3] and 11–41 % [11]
after CD and 11.5 % after gynecological and urological
surgery [12] when postoperative epidural analgesia was
used. Furthermore, lower extremity numbness incidencest rescue analgesic use within 48 h after CD between the groups,
h or was discontinued
ued epidural analgesia Discontinued epidural analgesia p-value
; 55.6 %) (12/27; 44.4 %)
] 1 [0–6] 0.5
4] 2 [0–5] 0.2
9] 2 [0–11] 0.61
14:33 23:28 ± 18:12 0.73
d by Mann–Whitney U-test for frequency of rescue analgesic use and by
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after CD [4], and 35.5 % after gynecological and urological
surgeries [12] when postoperative epidural analgesia was
used. In our study, numbness or motor weakness of lower
extremities occurred in 33.3 % of patients in the CSEA-
EDA group, and the site of epidural catheter insertion was
not correlated with this adverse effect. This result is com-
parable to that of the previous studies listed above. In
most cases, CSEA was performed with CSEA needle and
puncture site was L2/3–L4/5. In such cases, incidence of
numbness or motor weakness of lower extremities would
be expected to be much higher than that observed in our
study.
In this study, none of the patients in the CSEA-EDA
group were converted to general anesthesia or to intraop-
erative supplemental administration of local anesthetics.
Therefore, we concluded that the patients in both groups
received adequate anesthesia for CD. In addition, although
the average dose of spinal bupivacaine in the CSEA-EDA
group was significantly lower than that in the ITM group,
as shown in Anesthetic Methods (ITM group 9.75 ±
0.87 mg, CSEA-EDA 5.42 ± 0.97 mg, p < 0.001, Mann–
Whitney U-test), the average time to first rescue analgesic
use in the CSEA-EDA group was comparable to that in
the ITM group. These results suggested that epidural
anesthesia was effective for managing postoperative pain
after CD. There was no statistical significance in analgesic
efficacies between different intervertebral spaces of epi-
dural puncture site.
Moreover, we also found that 44 % of CSEA-EDA pa-
tients had discontinued epidural analgesia within 48 h of
CD because of lower extremity numbness and weakness
(33.3 %) and/or catheter trouble (18.5 %). When epidural
analgesia is discontinued, another rescue analgesic is
needed to manage postoperative pain. However, anal-
gesic efficacies within 24 h of CD were not significantly
different between the groups that discontinued epidural
analgesia within 48 h of CD and those that continued
analgesia. Postoperative analgesia in the early period
after CD might be crucial for postoperative pain control.
Though pruritus is not life-threatening, it can severely
impact recovery quality in CD patients administered
with opioids. Pruritus only occurred in the ITM group
with a similar incidence as previously reported [14–16].
Unfortunately, our retrospective data do not allow us to
comment on how pruritus affected postpartum recovery.
Conclusions
This retrospective cohort study had several limitations.
First, patient pain was not evaluated using a subjective
scale because this information was not in medical re-
cords. Therefore, postoperative pain was evaluated with
supplemental analgesic use. Second, retrospective studies
carry inherent biases because they are not randomizedor blinded. Lastly, our study included a relatively small
number of subjects.
In conclusion, our study suggests that ITM is as effect-
ive as CSEA-EDA in managing postoperative pain after
CD, but ITM does not inhibit early ambulation. Unfortu-
nately, pruritus can occur with ITM, and countermeasures
to prevent this should be considered.
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